| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.0045 | 1 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.003 | 1 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |